Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2025-12-24 @ 11:17 PM
NCT ID:
NCT03998956
Eligibility Criteria:
Inclusion Criteria:
* Informed consent signed.
* Age of 18 to 75 years old.
* Persistent or longstanding persistent atrial fibrillation (≥7 days), which is confirmed by Holter in recent six months.
* Willing to have catheter ablation for atrial fibrillation.
Exclusion Criteria:
* Accompanied by serious heart diseases including cardiac valvular diseases, congenital heart diseases, hypertrophic obstructive cardiomyopathy, acute myocardium infarction, unstable anginal pectoris and so on.
* Complete atrioventricular block.
* An acute stroke or contradiction of anti-coagulation.
* Hyperthyroidism.
* Having a history of catheter ablation of atrial fibrillation.
* Left atrial appendage thrombosis confirmed by transesophageal echocardiography.
* Pregnancy or lactation.
* Planning for pregnancy in the near future.
* Myopathy or active liver disease, including patients with sustained increase of serum transaminase of unknown reason and the ones with increased serum transaminase over three times the upper limit of normal.
* Patients of severe renal insufficiency with creatinine clearance lower than 30 ml/min.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT03998956
Study Brief:
Protocol Section:
NCT03998956